At Croissance Clinical Research Africa, we're dedicated to advancing healthcare across the African continent. Our journey began in 2013 with a vision to leverage contemporary technology and therapeutic expertise to empower our clients in achieving their goals. Committed to ethical practices and compliance, we ensure every clinical study is conducted with the utmost integrity, delivering high-quality, reliable data that meets international standards.
With a strong presence in India, Nepal, and now Africa, Croissance Clinical Research is dedicated to building partnerships and networks across the continent. We collaborate with leading public and private healthcare institutions, fostering innovation and capacity building to drive impactful research outcomes that address the unique healthcare challenges facing Africa today
Quality Assurance: Croissance Clinical Research Africa is proud to uphold ISO 9001:2015 and ISO 27001:2013 certifications, underscoring our commitment to excellence and adherence to rigorous quality standards. We prioritize transparency, accountability, and continuous improvement to ensure the integrity and reliability of our services.
Join Us advancing Health Care: Whether you're a pharmaceutical company, academic institution, healthcare provider, or research organization, Croissance Clinical Research Africa invites you to join us in our mission to transform healthcare across Africa. Together, we can pioneer groundbreaking research, drive innovation, and improve patient outcomes for generations to come.
Croissance Africa's future vision encompasses a comprehensive and impactful approach to advancing healthcare through innovation, collaboration, and excellence. Here's an elaboration on the envisioned future
Pioneering Health Care Advancements: Croissance Africa envisions itself at the forefront of healthcare innovation, spearheading groundbreaking advancements in vaccine research and development. Through cutting-edge technologies, novel methodologies, and a commitment to scientific rigor, Croissance aims to accelerate the discovery and delivery of life-saving vaccines.
Global Leadership in Vaccine Trials: Building on its reputation for excellence, Croissance Africa strives to emerge as a global leader in vaccine trials. By consistently delivering high-quality results and exceeding client expectations, Croissance aims to set the standard for excellence in clinical research, earning the trust and admiration of stakeholders worldwide.
Digital Transformation for Impact: Croissance Africa embraces digital transformation as a catalyst for positive change. By leveraging state-of-the-art digital technologies and data-driven insights, Croissance seeks to optimize processes, enhance efficiency, and drive meaningful impact in healthcare delivery. From streamlined trial management to real-time data analytics, Croissance aims to harness the power of digital innovation to revolutionize healthcare outcomes.
Empowering Communities Through Collaboration: Croissance Africa recognizes the importance of collaboration in achieving its mission. By fostering partnerships with governments, healthcare organizations, academia, and local communities, Croissance seeks to create a collaborative ecosystem focused on improving healthcare access and equity. Through shared knowledge, resources, and expertise, Croissance aims to empower communities to address healthcare challenges effectively and sustainably.
Sustainable Growth with Social Responsibility: Croissance Africa is committed to achieving sustainable growth while upholding its social responsibility. By prioritizing ethical conduct, environmental stewardship, and social impact, Croissance aims to create value not only for its stakeholders but also for society at large. From promoting diversity and inclusion to supporting community health initiatives, Croissance strives to be a responsible corporate citizen dedicated to making a positive difference in the world.
In summary, Croissance Africa's future vision is one of leadership, innovation, and collaboration, driven by a steadfast commitment to advancing healthcare and improving lives. Through its relentless pursuit of excellence and unwavering dedication to its mission, Croissance aims to shape a healthier, more prosperous future for generations to come.
Bernhards Ogutu is a Chief Research Officer at the Kenya Medical Research Institute (KEMRI), Senior Clinical Trialist with INDEPTH Network, and a Board Registered Pediatrician of the Kenya Medical Practitioners and Dentist Board. He is also a member of the Expert Committee on Clinical Trials of the Pharmacy and Poisons Board and the Regulatory Authority of the Kenyan Ministry of Health. He was instrumental in establishing the Malaria Diagnostic Centre of Excellence at KEMRI, Kisumu. Dr. Ogutu has extensive experience in malaria research and has been involved in a number of malaria vaccine and drug trials at the KEMRI Centres in Kisumu and Kilifi. He has published over 35 papers in peer-reviewed journals and authored two book chapters. Dr. Ogutu is actively involved in several scientific working groups in the field of malaria and clinical trials within and outside Africa.
James Aggrey Oloo Otieno is a Professor of Medicine and Associate Professor of Epidemiology and Preventive Medicine, with vast experience in clinical research and field based health research in sub Saharan Africa. He supported research planning, implementation and administration as director of a field research centre of Kenya Medical Research Institute in Kisumu Kenya. He was a WHO national office technical support for the Ministry of Health in Kenya on malaria control. As an International Professional Officer at WHO Regional Office for Africa supported member countries in malaria control policy elaboration based on evidence. He was a network director for African Malaria Network Trust (AMANET) and provided oversight for malaria candidate vaccines trials throughout the network in sub Saharan Africa. He is widely published in Communicable Diseases, and a reviewer for East African Medical Journal. Has supported establish new Medical Schools at Uzima University in Kisumu Kenya and Masinde Muliro University in Kakamega, Kenya.
Mr. Satish Marukurthi stands at the helm of Croissance Clinical Research as its Founder & CEO, driving the company's trajectory with innovative strategies and dynamic leadership. With an extensive involvement in shaping the organization, he has played a pivotal role in catapulting Croissance from a domestic entity to an esteemed International Clinical Research Organization (CRO) With a keen eye for growth opportunities and a penchant for innovation, Mr. Marukurthi has been instrumental in crafting and executing strategies that have significantly contributed to the success story of Croissance. His visionary leadership has not only propelled the company to new heights but has also positioned it as a frontrunner in the global clinical research landscape.
Pharmacist and biomedical researcher with various roles in the public health and clinical research arena, including infectious diseases, vaccine, treatment and prevention clinical trials in the region. Jackline is a seasoned professional in the industry with vast experience in quality management, executive project management, multi-country central study implementation and oversight, multi-centre site management, provision of technical, strategic and analytical advisory roles She is responsible for Clinical Trial Pharmacy and Clinical Supplies Affairs.
Bharathi Marukruthi, the Managing Director of Croissance, holds an MBA in Finance and has been instrumental in the company's journey since its inception. Her adept budgeting skills have provided the organization with essential expertise in financial management, giving it a competitive edge in its general operations and administration. With a keen eye for detail and strategic vision, Bharathi has played a pivotal role in steering Croissance through its formative years, ensuring its growth and success in the clinical research landscape.
Ms Sandhya Rani is a seasoned Sr. Manager in Clinical Data Management (CDM) at Croissance Clinical Research, Hyderabad. With over 18 years in Clinical Research, she specializes in CDM with 16+ years of hands-on experience. Proficient in global and local regulatory guidelines, she has worked across various CDMS tools, managing start-up to close-out activities. Her expertise spans Phase I to Phase IV studies and diverse therapeutic areas including Epidemiology and BA/BE studies. Skilled in team management, she excels in IM presentations, data trend analysis, and providing comprehensive training to site staff on e-CRF completion guidelines and CDMS tools.
Mr Giri Babu Gavireddy is an accomplished Manager in Clinical Data Management with a rich experience of over 16 years in the field. Proficient in CDISC/CDASH standards and adept at database design and management of CDMS tools, he oversees a wide array of CDM activities. With a portfolio boasting 75+ clinical trials spanning Phase I to IV and observational studies, he showcases expertise across numerous therapy areas including Oncology, Nephrology, Infectious Diseases, and more. His comprehensive knowledge and hands-on experience make him an invaluable asset in the clinical research landscape.
Dr. Mruthunjaya Ganiger, a proficient Project Manager at Croissance Clinical Research, Hyderabad, brings forth a wealth of experience in overseeing Phase II, III, and IV trials. With a notable accomplishment of leading seven Phase III studies from inception to completion, he showcases a robust history of success. His expertise spans project planning and execution, team leadership, budgetary control, CRO supervision, vendor collaboration, and stakeholder engagement. Proficient in CTMS, eTMF tools, REPCA, SAP, and various EDC platforms, he demonstrates a versatile skill set in clinical research management.
Vaishnavi Marukruthi is an integral member of our team, bringing over 6 years of dedicated expertise to Croissance. With a robust portfolio encompassing 30+ trials, her proficiency in data analysis, validations, and documentation Vaishnavi’s contributions extend beyond routine tasks; her insights during DSMB Charter meetings have proven invaluable, demonstrating her strategic thinking and deep understanding of clinical research processes. Her involvement in diverse projects including Phase I, II, and III PMS, Observational, and Survey Studies showcases her adaptability and proficiency across different study types. Vaishnavi consistently delivers exceptional results, ensuring the quality and integrity of our research endeavors. Driven by a passion for growth and excellence, Vaishnavi remains committed to advancing Croissance's mission and contributing to its continued success
Sujeet Naikwade is a seasoned Manager in Clinical Operations, boasting a robust seven-year tenure in the clinical research domain. With a solid foundation in scientific, technical, and commercial aspects, he adeptly caters to clients across industries. Specializing in site monitoring, site management, and project management, he has conducted over 200 monitoring visits, 40+ site initiation visits, and close-out visits. His extensive project involvement spans across India, Nepal, and African countries such as Madagascar, Mozambique, Rwanda, Kenya, and Tanzania. Having contributed to over 30 trials encompassing Phase I to IV PMOS and IIS, his expertise covers diverse therapy areas including Immunology, Endocrinology, Infectious Diseases, and more
Ms Nargis Jahan, as the HR Manager at Croissance Clinical Research, brings over 12 years of expertise and holds the prestigious SHRM-SCP credential. She specializes in delivering strategic HR solutions by analyzing trends, developing policies, and resolving complex employee relations issues while ensuring alignment with the company's values and vision. Nargis collaborates closely with management and employees to enhance work relationships, boost morale, and drive productivity and retention. Her responsibilities extend to providing guidance on performance management, interpreting HR policies, and offering support to expatriates. Additionally, she plays a pivotal role in business unit restructures, workforce planning, and succession management, thereby facilitating the achievement of organizational goals and objectives
Ravindra Kale, a seasoned Project Manager at Croissance Clinical Research, Hyderabad, boasts vast expertise in spearheading Phase II, III, and IV trials alongside Real-World Evidence studies. Proficient in Project Management, he excels in clinical study planning and execution, team and budget management, CRO oversight, vendor collaboration, and stakeholder engagement. Recognized for Operational Excellence, Ravindra underwent specialized training in Data Management and Risk-Based Monitoring (RBM) to augment his skill set. With a background in IT as a Business Analyst, he contributed significantly to application lifecycle development and Data Migration for leading pharmaceutical firms. His proficiency extends to CTMS, RAVE-Medidata, OC-RDC, Clin-admin, and JIRA platforms.
Savitha Viswanathan, a Senior Project Manager at Croissance Clinical Research in Hyderabad, boasts 17 years of dedicated experience in the field. Armed with a profound understanding of ICH-GCP guidelines, Clinical Research & Monitoring, and international Project Management, she excels in fostering strong sponsor-site relationships and timely SAE reporting. Renowned for her teamwork and communication prowess, Savitha ensures quality delivery to stakeholders while meticulously tracking project progress and implementing robust data collection procedures. Proficient in CTMS, RAVE EDC, Oracle Clinical, Inform, QRPM/RM, and Infosario, she has garnered numerous accolades for her outstanding performance and collaborative spirit throughout her career
Sai Krishna is a dynamic Finance Controller with over 6 years of experience in financial management, specializing in budgeting, forecasting, and analysis. With a proven track record of implementing effective financial strategies, he optimizes company performance and profitability. Possessing strong leadership skills, Sai collaborates cross-functionally to drive business initiatives while upholding the highest standards of integrity, accuracy, and compliance in all financial operations. With extensive experience in the clinical research sector, he brings a deep understanding of its unique financial challenges and regulatory requirements, supporting the achievement of research objectives through optimized financial processes. Committed to ensuring financial integrity, compliance, and transparency.
Dr. Srikanth is a seasoned medical professional specializing in cardiology, with a rich background of experience across multiple hospitals and companies. Currently serving as a Consultant in various hospitals and organizations, Dr. Srikanth brings a wealth of knowledge and expertise to the field of cardiology. Throughout his career, Dr. Srikanth has made significant contributions to the advancement of cardiology through his diverse roles and responsibilities. His understanding of the pharmaceutical industry in the context of Clinical Trials and its workings has been instrumental in driving progress and innovation, particularly benefiting Croissance and its endeavors in the medical field. With a dedication to patient care and a deep-rooted commitment to excellence, Dr. Srikanth continues to make a positive impact in the field of cardiology, improving healthcare outcomes and advancing medical research. His extensive experience and expertise make him a valuable asset to our organization or project he is involved in.
Ms Swarna is a skilled biostatistician with over four years of extensive experience in clinical research across India and Nepal. She specializes in providing crucial inputs to protocol development, SAP, SAR, and generating randomization, as well as conducting sample size calculations. Her expertise extends to actively participating in DSMB charter meetings for numerous projects. With a focus on Phase III and IV PMS trials and Observational Studies, she has contributed to over 15 trials. Ms. Swarna's therapeutic proficiency covers a wide range, including Endocrinology, Virology, Neurology, Wound Management, Gastroenterology, Infectious Diseases, Immunology (Vaccine), and Respiratory studies
To ensure each clinical study is conducted in ethical and safe manner that offers the highest possible quality with clean and accurate data, meeting international standards cost effectively on time, every time.
Croissance Clinical Research is fueled by morals and principles like providing customer satisfaction with quality and integrity. Collaborating and keeping open communication for constant improvement. Being environmentally responsible, having ethical conduct.
In next 5 years Croissance wants to be seen as a leading CRO in vaccine trials and proudly serve its customer. The future will be digital and the team is turning the table around in terms of formulating the right set of processes, developing required skills, adapting to new technologies and platform that can help them work more efficiently. Focus is to venture newer territories and countries where there is high unmet need for vaccines. Work closely with the government agencies to streamline processes for smooth conduct of trials. Croissance is investing wisely to create an ecosystem that can generate quality real world data in a more efficient manner and help its client meet the study objective.